Deerfield Management’s Inozyme Pharma INZY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-11,591
| Closed | -$51.7K | – | 550 |
|
|
2024
Q2 | $51.7K | Buy |
+11,591
| New | +$51.7K | ﹤0.01% | 426 |
|
|
2022
Q4 | – | Sell |
-2,090,436
| Closed | -$5.6M | – | 113 |
|
|
2022
Q3 | $5.6M | Sell |
2,090,436
-605,936
| -22% | -$1.62M | 0.11% | 93 |
|
|
2022
Q2 | $12.9M | Buy |
2,696,372
+351,586
| +15% | +$1.68M | 0.27% | 70 |
|
|
2022
Q1 | $9.59M | Hold |
2,344,786
| – | – | 0.21% | 75 |
|
|
2021
Q4 | $16M | Hold |
2,344,786
| – | – | 0.34% | 66 |
|
|
2021
Q3 | $27.2M | Buy |
2,344,786
+165,801
| +8% | +$1.92M | 0.53% | 54 |
|
|
2021
Q2 | $37.1M | Buy |
2,178,985
+214,985
| +11% | +$3.66M | 0.66% | 51 |
|
|
2021
Q1 | $38.9M | Buy |
1,964,000
+813,701
| +71% | +$16.1M | 0.82% | 43 |
|
|
2020
Q4 | $23.7M | Hold |
1,150,299
| – | – | 0.47% | 65 |
|
|
2020
Q3 | $30.2M | Buy |
+1,150,299
| New | +$30.2M | 0.74% | 39 |
|